Current Pharmaceutical Design
Volume 26, 46 Issues, 2020
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Pharmaceutical Design, Volume 20 - Number 42
Editorial
Editorial (Thematic Issue: Combined Cancer Therapy)
, 20(42): 6511 - 6512Jasminka Pavelic
DOI: 10.2174/1381612820666140826154834
Combining Oncolytic Virotherapy and Cytotoxic Therapies to Fight Cancer
, 20(42): 6513 - 6521Cristina Fillat, Maria Victoria Maliandi, Ana Mato-Berciano and Ramon Alemany
DOI: 10.2174/1381612820666140826152420
Anti-Metastatics: An Overview of Drug Candidates in Current Pipelines
, 20(42): 6522 - 6528Anne Schaap-Nutt, Dane A. Thyssen, David W. Drell and Frank Entschladen
DOI: 10.2174/1381612820666140826152610
Oxidative Stress and Antioxidants in Carcinogenesis and Integrative Therapy of Cancer
, 20(42): 6529 - 6542Lidija Milkovic, Werner Siems, Renate Siems and Neven Zarkovic
DOI: 10.2174/1381612820666140826152822
Attacking c-Myc: Targeted and Combined Therapies for Cancer
, 20(42): 6543 - 6554Huilin Huang, Hengyou Weng, Hui Zhou and Lianghu Qu
DOI: 10.2174/1381612820666140826153203
The Exploitation of Toll-like Receptor 3 Signaling in Cancer Therapy
, 20(42): 6555 - 6564Tanja Matijevic Glavan and Jasminka Pavelic
DOI: 10.2174/1381612820666140826153347
NCRNA Combined Therapy as Future Treatment Option for Cancer
, 20(42): 6565 - 6574Cornelia Braicu, Cristina Catana, George A. Calin and Ioana Berindan-Neagoe
DOI: 10.2174/1381612820666140826153529
Combined Cancer Therapy: Strategies to Overcome Acquired Aromatase Inhibitor Resistance
, 20(42): 6575 - 6583Susan B. Kesmodel, Gauri J. Sabnis, Saranya Chumsri and Angela M.H. Brodie
DOI: 10.2174/1381612820666140826153711
Immunotoxins Constructed with Ribosome-Inactivating Proteins and their Enhancers: A Lethal Cocktail with Tumor Specific Efficacy
, 20(42): 6584 - 6643Roger Gilabert-Oriol, Alexander Weng, Benedicta von Mallinckrodt, Matthias F. Melzig, Hendrik Fuchs and Mayank Thakur
DOI: 10.2174/1381612820666140826153913
A Comprehensive Review of Poorly Differentiated Neuroendocrine Carcinomas (pdNECs): a Niche to Find Novel Opportunities
, 20(42): 6644 - 6651Pablo Reguera, Ainhoa Madariaga and Enrique Grande
DOI: 10.2174/1381612820666140826154033
Pancreatic Cancer: Systemic Combination Therapies for a Heterogeneous Disease
, 20(42): 6660 - 6669Davide Melisi, Lorenzo Calvetti, Melissa Frizziero and Giampaolo Tortora
DOI: 10.2174/1381612820666140826154327
Mechanism-based Combinations with Pim Kinase Inhibitors in Cancer Treatments
, 20(42): 6670 - 6681Qingshan Yang, Lisa S. Chen and Varsha Gandhi
DOI: 10.2174/1381612820666140826154451
Curcumin in Combined Cancer Therapy
, 20(42): 6682 - 6696Koraljka Gall Troselj and Renata Novak Kujundzic
DOI: 10.2174/1381612820666140826154601
Combined Modality Therapy in Pancreatic Adenocarcinoma: Review and Updates on a Controversial Issue
, 20(42): 6697 - 6701Ludimila Cavalcante, David P. Kelsen and Kenneth H. Yu
DOI: 10.2174/1381612820666140826154724
Molecular Mechanisms Involved in the Control of Neurohypophyseal Hormones Secretion
, 20(42): 6702 - 6713M. Iovino, E. Guastamacchia, V.A. Giagulli, B. Licchelli, E. Iovino and V. Triggiani
DOI: 10.2174/1381612820666140905150730
The Molecular Mechanisms of TRAIL Resistance in Cancer Cells: Help in Designing New Drugs
, 20(42): 6714 - 6722Feng Wang, Junsheng Lin and Ruian Xu
DOI: 10.2174/1381612820666140929100735
Executive Editor
Atta-ur-Rahman, FRS
(29381 citations)
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
(UK)
Biography
(29381 citations)
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
Biography
Biography of Atta-ur-Rahman
Prof. Atta-ur-Rahman, Ph.D. in organic chemistry (Cambridge University, 1968), has over 1,055 international publications including 210 books. He won the UNESCO Science Prize (1999) and was elected Fellow of Royal Society (London, 2006). He was conferred honorary doctorate degrees by many universities including Cambridge University and many others. Furthermore, Prof. Atta-ur-Rahman was elected Honorary Life Fellow of Kings College, Cambridge University, and the Austrian government honoured him with its high civil award “Grosse Goldene Ehrenzeischen am Bande" (2007). He is the only scientist from the Muslim world to be Foreign Fellow (“Academician”) of Chinese and Korean Academies of Sciences. The University of Technology Mara (UiTM), Malaysia, has established “Atta-ur-Rahman Institute of Natural Product Discovery” in his honour. Prof. Atta-ur-Rahman was the Federal Minister of Science and Technology of Pakistan, and he is Chairman of UN Committee on Science, Technology and Innovation for UNESCAP region covering 62 countries.
View Full Editorial Board
Nobel Laureate on Editorial Board
Andrew V. Schally
(USA)
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Pharmaceutical Design was introduced in 1995 with the assistance of Dr. William A. Banks.
Scopus CiteScore Metrics: 2.32
Advertisement
Webmaster Contact: info@benthamscience.net